Halim, F.; Azhar, Y.; Suwarman, S.; Wahjoepramono, E.J.; Hernowo, B.
Positive p53 Expression Is Associated with Primary Endocrine Therapy Resistance in Locally Advanced Stage Luminal B HER2-Negative Breast Cancer Patients: A Cross-Sectional Study in Indonesia. Diagnostics 2023, 13, 1838.
https://doi.org/10.3390/diagnostics13111838
AMA Style
Halim F, Azhar Y, Suwarman S, Wahjoepramono EJ, Hernowo B.
Positive p53 Expression Is Associated with Primary Endocrine Therapy Resistance in Locally Advanced Stage Luminal B HER2-Negative Breast Cancer Patients: A Cross-Sectional Study in Indonesia. Diagnostics. 2023; 13(11):1838.
https://doi.org/10.3390/diagnostics13111838
Chicago/Turabian Style
Halim, Freda, Yohana Azhar, Suwarman Suwarman, Eka Julianta Wahjoepramono, and Bethy Hernowo.
2023. "Positive p53 Expression Is Associated with Primary Endocrine Therapy Resistance in Locally Advanced Stage Luminal B HER2-Negative Breast Cancer Patients: A Cross-Sectional Study in Indonesia" Diagnostics 13, no. 11: 1838.
https://doi.org/10.3390/diagnostics13111838
APA Style
Halim, F., Azhar, Y., Suwarman, S., Wahjoepramono, E. J., & Hernowo, B.
(2023). Positive p53 Expression Is Associated with Primary Endocrine Therapy Resistance in Locally Advanced Stage Luminal B HER2-Negative Breast Cancer Patients: A Cross-Sectional Study in Indonesia. Diagnostics, 13(11), 1838.
https://doi.org/10.3390/diagnostics13111838